Carmignac Gestion Medtronic PLC Transaction History

Carmignac Gestion

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$99.53 - $127.75 $48.5 Million - $62.2 Million	-486,813 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $42.2 Million - $46.4 Million	-343,530 Reduced 41.37%	486,813 $61 Million
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $80.8 Million - $89.9 Million	-683,861 Reduced 45.16%	830,343 $103 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $13.4 Million - $14.4 Million	120,417 Added 8.64%	1,514,204 $179 Million
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $22.5 Million - $26.2 Million	223,924 Added 19.14%	1,393,787 $163 Million
Q3 2020 Nov 13, 2020	SELL	$90.13 - $108.78 $243,351 - $293,706	-2,700 Reduced 0.23%	1,169,863 $122 Million
Q2 2020 Aug 13, 2020	BUY	$84.11 - $103.33 $98.6 Million - $121 Million	1,172,563 New	1,172,563 $108 Million
Q3 2019 Nov 13, 2019	SELL	$98.02 - $111.18 $74.5 Million - $84.5 Million	-760,033 Closed	0 $0
Q2 2019 Aug 13, 2019	SELL	$84.15 - $99.38 $62.3 Million - $73.6 Million	-740,199 Reduced 49.34%	760,033 $74 Million
Q1 2019 May 14, 2019	BUY	$82.45 - $93.79 $124 Million - $141 Million	1,500,232 New	1,500,232 $137 Million

2,285

1.02B

8.05M

7.19M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $113B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.